A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancer

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 2, 1998, Pages 141-150

  Schwartzberg, L S ^a   Weaver, C H ^a   Birch, R ^a   Manner, C ^a   Tauer, K ^a   Beeker, T ^a   Morgan Ihrig, C ^a   MacAneny, B ^a   Leff, R ^a   Smith, R ^a   Hainsworth, J ^a   Greco, T ^a   Schwerkoske, J ^a   Murphy, M N ^a   Buckner, C D ^a,b  

^a Clin Res Div Response Oncol I   (United States)

^b Response Oncology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; THIOTEPA;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VOMITING;

EID: 0031958069     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1998.7.141     Document Type: Article

References (47)

1. Barr, R. & McBride, J. Haemopoietic engraftment with peripheral blood cells in the treatment of malignant disease. Br. J. Haematol. 51:181, 1982.
2. Kessinger, A., Armitage, J.O., Landmark, J.D., et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 71:723, 1988.
3. Kessinger, A., Armitage, J.O., Smith, D.M., et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74:1260, 1989.
4. Brice, P., Marolleau, J.P., Dombret, H., et al. Autologous peripheral blood stem cell transplantation after high-dose therapy in patients with advanced lymphomas. Bone Marrow Tranplant. 9:337, 1992.
5. Elias, A.D., Ayash, L., Anderson, K.D., et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036, 1992.
6. Sheridan, W.P., Begley, C.G., Juttner, C.A., et al. Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1:640, 1992.
7. Hohaus, S., Goldschmidt, H., Ehrhardt, R., et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp. Hematol. 21:508, 1993.
8. Pettengall, R., Testa, N.G., Swindell, R., et al. Transplantation potential of hematopoetic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 82:2239, 1993.
9. Schwartzberg, L., Birch, R., Blanco, R., et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant. 11:369, 1993.
10. Bensinger, W.I., Longin, K., Appelbaum, F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87:825, 1994.
11. Haas, R., Möhle, R., Frühauf, S., et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994.
12. Bensinger, W., Appelbaum, F., Rowley, S., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J. Clin. Oncol. 13:2547, 1995.
13. Nademanee, A., Sniecinzki, I.J., Schmidt, C.A., et al. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral blood stem cells. J. Clin. Oncol. 12:2176, 1995.
14. Weaver, C.H., Hazelton, B., Birch, R., et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961, 1995.
15. Weaver, C.H., Schwartzberg, L.S., Li, W., et al. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease. Bone Marrow Transplant. 17:715, 1996.
16. Copelan, E., Ceselski, S., Ezzone, S., et al. Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma and Hodgkin's disease. J. Clin. Oncol. 15:759, 1997.
17. Weaver, C.H., Schwarzberg, L.S., Hainsworth, J., et al. Treatment-related mortality in 1,000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers. Bone Marrow Transplant. 19:671, 1997.
18. Weaver, C.H., West, W.H., Schwartzberg, L.S., et al. Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: Outcomes by intent to treat analyses. Bone Marrow Transplant. 19:661, 1997.
19. Bensinger, W.I., Singer, J., Appelbaum, F., et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993.
20. Weaver, C.H., Birch, R., Greco, F.A., et al. Mobilization and harvesting of peripheral blood stem cells: A randomized dose escalation trial of filgrastim. Br. J. Haematol. 100:338, 1998.
21. Shepherd, K.M., Charles, P., Sage, R.E., et al. Mobilization of haemopoietic stem cells by cyclophosphamide into the peripheral blood of patients with haematological malignancies. Clin. Lab. Haematol. 13:25, 1991.
22. Haas, R., Hohaus, S., Egerer, G., et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplant. 9:459, 1992.
23. Kotasek, D., Shepherd, K.M., Sage, R.E., et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant. 9:11, 1992.
24. Schwartzberg, L., Birch, R., Hazelton, B., et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J. Hematother. 1:317, 1992.
25. Dreger, P., Marquardt, P., Haferlach, T., et al. Effective mobilisation of peripheral blood progenitor cells with "Dexa-BEAM" and G-CSF: Timing of harvesting and composition of the leukapheresis product. Br. J. Cancer 68:950, 1993.
26. Henon, P.R. & Becker, M. Cytokine enhancement of peripheral blood stem cells [Review]. Stem Cells 11 (Suppl 2): 65, 1993.
27. Weaver, C.H., Schwartzberg, L.S., Birch, R., et al. Collection of peripheral blood stem cells following the administration of paclitaxel, cyclophosphamide and filgrastim in patients with breast and ovarian cancer. Biol. Blood Marrow Transplant. 3:83, 1997.
28. Weaver, C.H., Schwartzberg, L.S., Birch, R., et al. Collection of peripheral blood progenitor cells following the administration of cyclophosphamide, etoposide and granulocyte-colony stimulating factor: An analysis of 497 patients. Transfusion 37:896, 1997.
29. Demirer, T., Buckner, C.D., & Bensinger, W.I. Optimization of peripheral blood stem cell mobilization. Stem Cells 14:106, 1996.
30. Demirer, T., & Bensinger, W.I. Optimization of peripheral blood stem cell collection. Curr. Opin. Hematol. 2:219, 1995.
31. American Joint Committee on Cancer. Manual for Staging of Cancer. J.B. Lippincott, Philadelphia, 1988.
32. American Society of Clinical Oncology and American Society of Hematology. Recommended criteria for the performance of bone marrow transplantation. J. Clin. Oncol. 8:563, 1990.
33. Green, S. & Weiss, G.R. Southwest Oncology Group standard response criteria, end point definitions and toxicity criteria. Invest. New Drugs. 10:239, 1992.
34. Weaver, C., Birch, R., Schwartzberg, L., et al. High-dose chemotherapy and autologous stem cell transplantation for breast cancer. In Technical and Biological Components of Marrow Transplantation, eds. Buckner, C.D. & Clift, R. Kluwer Academic Publishers, Boston, 1995, p. 59.
35. Kaplan, E.L. & Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457, 1958.
36. Janssen, W., Smilee, R., Carter, R., et al. Mobilization of peripheral blood stem cells: Comparing cyclophosphamide and growth factor based regimens. Prog. Clin. Biol. Res. 389:429, 1993.
37. Demirer, T., Rowley, S., Buckner, C.D., et al. Peripheral blood stem-cell collections after paclitaxel, cyclophosphamide and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J. Clin. Oncol. 13:1714, 1995.
38. Passos-Coelho, J.L., Ross, A.A., Moss, T.J., et al. Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 85:1138, 1995.
39. Gianni, A., Bregni, M., Siena, S., et al. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J. Clin. Oncol. 8:768, 1990.
40. Ravagnani, F., Siena, S., Bregni, M., et al. Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur. J. Cancer 26:562, 1990.
41. Juttner, C.A., & To, L.B. Mobilization by myelosuppressive chemotherapy. In Autologous Bone Marrow Transplantation Proceedings of the Fifth International Symposium, Omaha, NE, eds. Dicke, K., Armitage, J. & Dicke-Enger, M. 1991, p. 9783.
42. Indovina, A., Majolino, I., Scimíe, R., et al. High dose cyclophosphamide: Stem cell mobilizing capacity in 21 patients. Leuk. Lymphoma 14:71, 1994.
43. To, L.B., Shepperd, M., Haylock, D.N., et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp. Hematol. 18:442, 1990.
44. 2 in patients with advanced cancer. Aust. N. Z. J. Med. 22:660, 1992.
45. Demirer, T., Buckner, C.D., Storer, B., et al. Effect of different chemotherapy regimens on peripheral blood stem cell collections in patients with breast cancer receiving granulocyte-colony stimulating factor. J. Clin. Oncol. 15:684, 1997.
46. Weaver, C., Schwartzberg, L., Zhen, B., et al. Mobilization of PBSC with cyclophosphamide and etoposide with or without cisplatin in patients with malignant lymphoma. Am. J. Clin. Oncol. In press.
47. Weaver, C., Schwartzberg, L., Zhen, B., et al. Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields. J. Clin. Apheresis. In press.